The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: clindamycin     Quarter: 2016Q3

Total Records: 475     Number of Pages: 24

DRUGNAME PT EventCount
CLINDAMYCIN HCL MG CAP AURO, 150 MG Abdominal discomfort 1
CLINDAMYCIN HCL MG CAP AURO, 150 MG Diarrhoea 1
CLINDAMYCIN HCL MG CAP AURO, 150 MG Impaired work ability 1
CLINDAMYCIN HCL MG CAP AURO, 150 MG Rectal haemorrhage 1
CLINDAMYCIN HCL ORAL CAPSULE 300 Dysphagia 1
CLINDAMYCIN HCL ORAL CAPSULE 300 Inappropriate schedule of drug administration 1
CLINDAMYCIN HCL ORAL CAPSULE 300 Lip swelling 1
CLINDAMYCIN HYDROCHLORIDE. Enanthema 1
CLINDAMYCIN HYDROCHLORIDE. Endothelial dysfunction 1
CLINDAMYCIN HYDROCHLORIDE. Musculoskeletal stiffness 1
CLINDAMYCIN HYDROCHLORIDE. Neck pain 1
CLINDAMYCIN HYDROCHLORIDE. Posterior reversible encephalopathy syndrome 1
CLINDAMYCIN HYDROCHLORIDE. Skin exfoliation 1
CLINDAMYCIN HYDROCHLORIDE. Urticaria 1
CLINDAMYCIN PALMITATE HYDROCHLORIDE. Abdominal discomfort 1
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE Application site discolouration 1
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE Application site dryness 1
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE Application site exfoliation 1
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE Application site irritation 1
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE Application site rash 1

Total Records: 475     Number of Pages: 24